Latest price information, how much does Ensidipine cost?

Enasidenib , as a specialized isocitrate dehydrogenase2 inhibitor, is an important drug for the treatment of relapsed or refractory acute myeloid leukemia with isocitrate dehydrogenase 2 mutations. However, unfortunately, this drug has not yet been officially launched in the domestic market, and therefore has not been included in my country's medical insurance system. This undoubtedly brings additional troubles and treatment difficulties to patients who urgently need this drug to save their lives.

But fortunately, patients are not completely helpless. Formal overseas drug purchasing channels provide them with a glimmer of hope. Especially in countries such as Laos and Bangladesh, officially approved generic drugs of ensidipine are already on the market. These generic drugs are highly consistent with the original drugs in terms of core drug ingredients, so their efficacy is also similar, bringing new treatment options to patients.

For those patients with limited financial conditions, the pharmaceutical ingredients of these generic drugs are basically the same as those of the original drugs, and the prices are more affordable, which is undoubtedly great news. Specifically, each box of ensidipine generic medicine in Laos contains 30 tablets of 50mg, and the current market price is about 2,200 yuan. The Bangladeshi version of ensidipine is available in 50 mg and 60 tablets, and its latest selling price is around 5,000 yuan. Compared with original drugs, these two prices are obviously more acceptable to the majority of patients.

Of course, when choosing these generic drugs, patients also need to make informed decisions based on their physical condition, financial ability and actual needs. More importantly, the channels chosen to purchase drugs must be formal and legal, so as to ensure that the rights and safety of patients are not violated.